leisure time -WSS

leisure time

author：focus 2025-10-01 13:59:23 - browse：8

Adam's take main illustration — Molly Ferguson/STAT

Roivant Sciences’ Matt Gline might be this year’s best biopharma CEO, and other thoughts about Monday’s blockbuster deal with Roche — like, why the heck did Roivant’s stock trade down?

Gline created $5 billion from $50 million — in less than one year.Regular readers know that every December, I choose a best biopharma CEO. It’s a subjective award, but deal-making acumen, management skills, and delivering shareholder value are important measuring sticks. It’s still too early to call this year’s contest, but Gline is a front-runner.

Last December, Roivant essentially acquired an experimental treatment for inflammatory bowel disease called RVT-3101 from Pfizer for $45 million and then spent another $5 million to position the drug for future Phase 3 studies. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Abbott's new heart device gets FDA advisory panel nod

focus

WSS

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Study gives hint on South Asians’ higher risk of cardiovascular disease

Caitlin Bernard's story shows physicians can't shy from advocacy

Tome Biosciences co

Here’s what’s in the FDA plan to include pregnant women in clinical trials

hotspot

leisure time

hotspot

Psychedelics group wrestles with new pharma identity

Organ transplantation is at a crossroads. Major reform is needed

Continuity nursing helped my family in our darkest PICU moments

Caitlin Bernard's story shows physicians can't shy from advocacy

The cancer drug shortage isn’t new — and neither are the solutions

Organ transplantation is at a crossroads. Major reform is needed

Guidelines to prevent youth baseball injuries need more muscle

New rules on organ donation and transplantation 'will bring chaos'

Medical records are filled with copy

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

focus

FDA official pushes for dedicated emerging pathogens team

Providers still hesitate to prescribe buprenorphine, study finds

Court strikes down limits on filming of police in Arizona

Why don't Americans have at

In new study, freeze

AbbVie dramatically boosts its spending on lobbying

leisure time

focus

explore

hotspot